Pharmacogenetic testing and therapeutic drug monitoring are feasible in the inpatient psychiatric treatment setting.

Emergency medical services runs increased in all 4 US Census regions.

It is crucial to have a measure to mitigate the possibility of seizures, according to researchers.

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

Investigators found a robust antigen-specific antibody response against HIV and Zika virus between mothers and newborns in a model using rabbits.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

All children included in the analysis with presymptomatic SMA achieved swallowing, oral nutrition, and airway protection outcomes.

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

Crunching the numbers can help pharmacies stay on top of their inventory.

What kind of technologies help pharmacies stay organized when taking and keeping inventory?

The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.

The 2023 AAP Annual Conference will take place in New Orleans from April 20 to 22.

How can current Alzheimer disease treatments be used to best treat patients living with the disease?

As sessions end for the day, head out to explore the city of Phoenix.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

The drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.

Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.